Inactive Instrument

Analyst Reco. Majesco Entertainment Co. Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 22	North American Morning Briefing : Stocks Struggle After New Records	DJ
Feb. 26	PolarityTE Screens First Subject in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers	CI

Northland Securities Adjusts Price Target on PolarityTE to $1 From $1.25, Maintains Outperform Rating	22-12-28	MT
Cantor Fitzgerald Downgrades PolarityTE to Neutral From Overweight, Adjusts Price Target to $1 From $2.50	22-03-31	MT

No results for this search